AIMD - Latest News

Ainos, Inc. (AIMD), operates in Technology / Biotechnology, trades on NASDAQ.

Market capitalization stands near $8.6M. Beta to the broader market is 2.45.

The article list below shows the most recent AIMD headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent AIMD Headlines

VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence

accessnewswire.com - Jun 22, 2026

HOUSTON, TX / ACCESS Newswire / June 22, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing sce

Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program

accessnewswire.com - Jun 17, 2026

Program expands Ainos' Smell AI platform from environmental intelligence into digital breath intelligence for emergency medicine research HOUSTON, TX

Ainos Releases 2026 Mid-Year CEO Letter to Shareholders

accessnewswire.com - Jun 8, 2026

Building the Olfactory Layer of Physical AI Highlighting Progress Across Semiconductor Manufacturing, Healthcare Infrastructure and Physical AI Applic

VASRO Research Highlights Ainos Smell AI Expansion into Emergency Department Operations

accessnewswire.com - Jun 5, 2026

HOUSTON, TX / ACCESS Newswire / June 5, 2026 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scen

Zacks SCR Discusses Ainos' Expansion of Smell AI into Healthcare Infrastructure Through NTUH Study

accessnewswire.com - Jun 3, 2026

HOUSTON, TX / ACCESS Newswire / June 3, 2026 / Ainos, Inc. (NASDAQ:AIMD, AIMDW) ("Ainos" or the "Company"), a Smell AI company digitizing scent into

How News Affects AIMD Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track AIMD's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked AIMD news questions

What is the latest AIMD news headline?
The most recent AIMD headline (Jun 22, 2026) is "VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the AIMD news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What AIMD news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual AIMD options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.